Yestar Healthcare Holdings Co (HKSE:02393) EPS (Basic): HK$-0.04 (TTM As of Dec. 2025)


What is Yestar Healthcare Holdings Co EPS (Basic)?

Yestar Healthcare Holdings Co HKSE:02393 -5.80% EPS (Basic) is HK$-0.04 as of Dec. 2025. The stock has 6 warning signs investors should review.

Yestar Healthcare Holdings Co's basic earnings per share (Basic EPS) for the six months ended in Dec. 2025 was HK$-0.04. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-0.04.

Yestar Healthcare Holdings Co's EPS (Diluted) for the six months ended in Dec. 2025 was HK$-0.04. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-0.04.

Yestar Healthcare Holdings Co's EPS without NRI for the six months ended in Dec. 2025 was HK$-0.03. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was -0.03.

During the past 12 months, Yestar Healthcare Holdings Co's average EPS without NRIGrowth Rate was -400.00% per year. During the past 3 years, the average EPS without NRI Growth Rate was 42.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Yestar Healthcare Holdings Co's highest 3-Year average EPS without NRI Growth Rate was 54.80% per year. The lowest was -68.90% per year. And the median was 26.00% per year.

Yestar Healthcare Holdings Co  (HKSE:02393) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Yestar Healthcare Holdings Co EPS (Basic) Related Terms

Yestar Healthcare Holdings Co EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Yestar Healthcare Holdings Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Yestar Healthcare Holdings Co EPS (Basic) Chart

Yestar Healthcare Holdings Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -0.48 -0.01 0.42 -0.04

Yestar Healthcare Holdings Co Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 0.50 -0.08 0.00 -0.04

Yestar Healthcare Holdings Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Yestar Healthcare Holdings Co's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-82.888-0)/2331.590
=-0.04

Yestar Healthcare Holdings Co's Basic EPS for the quarter that ended in Dec. 2025 is calculated as

Basic EPS (Q: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-89.252-0)/2331.590
=-0.04

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of HK$-0.04 mean?
Yestar Healthcare Holdings Co (HKSE:02393) has a EPS (Basic) of HK$-0.04 as of Dec. 2025. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Yestar Healthcare Holdings Co and its competitors.
Is Yestar Healthcare Holdings Co's EPS (Basic) too high?
Yestar Healthcare Holdings Co's current EPS (Basic) is HK$-0.04.
How does Yestar Healthcare Holdings Co's EPS (Basic) compare to ABT and SYK?
Yestar Healthcare Holdings Co's EPS (Basic) of HK$-0.04 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Medical Devices & Instruments company?
A good EPS (Basic) depends on the Medical Devices & Instruments industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Yestar Healthcare Holdings Co and its competitors. Yestar Healthcare Holdings Co's current EPS (Basic) is HK$-0.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yestar Healthcare Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Yestar Healthcare Holdings Co (HKSE:02393) is currently considered Fairly Valued. The stock's GF Value™ is HK$0.07, compared to a current price of HK$0.07 — trading 7.1% below its estimated fair value. The current EPS (Basic) is HK$-0.04. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Yestar Healthcare Holdings Co (HKSE:02393), the current EPS (Basic) is HK$-0.04 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Yestar Healthcare Holdings Co Business Description

Address No. 1, Lane 388, Kang’an Road, Room 1210-1213, 12th Floor, Building T1, Pudong New District, Shanghai, CHN
Yestar Healthcare Holdings Co Ltd is engaged in the manufacture, distribution, and sale of medical imaging products, distribution of In Vitro Diagnostic (IVD) products, and manufacture and sale of dental films. The Group has two reportable operating segments: Imaging printing products segment, which includes the manufacture and sale of colour photographic paper, industrial NDT x-ray films and PWB films, and trading of imaging equipment; and Medical products and equipment segment, which generates maximum revenue and includes manufacture and sale of medical dry films, medical wet films and dental films, and sale of medical equipment and diagnostic reagents. The Group operates its business in Mainland China.